ONCOLYSIN
Dead / Cancelled — Cancelled — Section 8 (as of 05 Dec 2025)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87834162
- Registration number
- 5758884
- Mark type
- Stylized text
- Filed
- 14 Mar 2018
- Published for opposition
- 31 Jul 2018
- Registered
- 21 May 2019
- Attorney of record
- Perry Y. Woo
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations, for use in the field of oncology, namely, for the treatment of cancer
Owner
- ONCOLYZE, INC., New York, NY, US
- ONCOLYZE, INC., New York, NY, US
- ONCOLYZE, INC., New York, NY, US
Prosecution history
- 05 Dec 2025 — CANCELLED SEC. 8 (6-YR)
- 21 May 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 21 May 2019 — REGISTERED-PRINCIPAL REGISTER
- 13 Apr 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 12 Apr 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Apr 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 21 Mar 2019 — USE AMENDMENT FILED
- 06 Apr 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 21 Mar 2019 — TEAS STATEMENT OF USE RECEIVED
- 25 Sept 2018 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 31 Jul 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Jul 2018 — PUBLISHED FOR OPPOSITION
- 11 Jul 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Jun 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Jun 2018 — ASSIGNED TO EXAMINER